Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZIK1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | SUGT1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | LRRC37A | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | RASGEF1B | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | FKBP6 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | CAMK2N2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | BRSK1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | CDKAL1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | KIAA2022 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | CLIP1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |